Yang-xin Fu
Professor
Institute of Biophysics
Chinese Academy of Sciences
China
Biography
1978-1983 Shanghai Medical University，China, MD equivalent 1983-1986 PUMC Hospital, Chinese Academy of Medical Sciences, Resident 1986-1990 University of Miami School of Medicine, PhD
Research Interest
The major research interest of Fu lab is to explore new immunological therapeutic strategies for cancer and chronic infection using antibody-based strategies and therapeutic vaccines. Our lab has made significant progress in understanding how traditional cancer therapies both rely on and impact the immune system. We also started the projects of comprehensive strategies to prevent and treat chronic HBV infection.
Publications
-
PD-1 Shapes B Cells as Evildoers in the Tumor Microenvironment. Ren Z, Peng H, Fu YX, Cancer Discov 2016 May 6 5 477-8
-
Combination of radiotherapy and vaccination overcome checkpoint blockade resistance. Zheng W, Skowron KB, Namm JP, Burnette B, Fernandez C, Arina A, Liang H, Spiotto MT, Posner MC, Fu YX, Weichselbaum RR Oncotarget 2016 Jun
-
CTLA-4 limits anti-CD20-mediated tumor regression. Ren Z, Guo J, Liao J, Luan Y, Liu Z, Sun Z, Liu X, Liang Y, Peng H, Fu YX, Clin. Cancer Res. 2016 Jun
